Publication | Open Access

Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of Type 1 (insulin-dependent) diabetes mellitus in high risk individuals

Metabolic SyndromeType 1Diabetes EpidemiologyAutoimmune DiseaseMedicineDiabetesImmunologyAutoimmunityAutoantibodiesDiabetes MellitusHigh Risk IndividualsGlutamic Acid Decarboxylase